Related Experiment Video
Updated: Jun 27, 2026
08:17
Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo
Published on: September 22, 2017
Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma
Yutao Liu1, Stephen Akafo, Cecile Santiago-Turla
1Center for Human Genetics, Duke University Medical Center, Durham, NC, USA.
Molecular Vision
|December 20, 2008
Summary
Coding variants in the optineurin gene (OPTN) are not associated with primary open-angle glaucoma (POAG) risk in West African populations. This study found no significant differences in OPTN variant frequencies between POAG cases and controls in Ghana.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Optineurin gene (OPTN) variants are linked to primary open-angle glaucoma (POAG) in diverse populations.
- Understanding the role of OPTN in POAG is crucial for identifying genetic risk factors.
Purpose of the Study:
- To investigate the association of OPTN sequence variants with POAG in a Ghanaian population from West Africa.
- To determine if OPTN coding variants contribute to POAG risk in this specific ethnic group.
Main Methods:
- A case-control study involving 140 unrelated Ghanaian POAG patients and 130 non-glaucomatous controls.
- Sequencing of all coding exons of the OPTN gene in all participants.
- Analysis of variant frequencies between POAG cases and controls.
Main Results:
- Several OPTN coding variants were identified, including three novel variants (V147L, P292P, A301G).
- No statistically significant differences were observed in the frequencies of identified OPTN variants between POAG cases and controls.
- This comprehensive analysis represents the first study of OPTN in a West African cohort.
Conclusions:
- Coding variants in the optineurin gene (OPTN) do not appear to be a significant risk factor for primary open-angle glaucoma (POAG) in individuals of West African descent.
- Further research may be needed to explore other genetic or environmental factors contributing to POAG in this population.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...